rss
J Med Genet 2007;44:579-585 doi:10.1136/jmg.2007.049981
  • Original article

Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers

  1. K L Lachlan1,2,
  2. A M Lucassen1,3,
  3. D Bunyan4,
  4. I K Temple1,2
  1. 1Wessex Clinical Genetics Service, Southampton University Hospitals Trust, Southampton, UK
  2. 2Division of Human Genetics, Southampton Medical School, University of Southampton, Southampton, UK
  3. 3Division of Cancer Sciences, Southampton Medical School, University of Southampton, Southampton, UK
  4. 4Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK
  1. Correspondence to:
 Dr Katherine Lachlan
 Wessex Clinical Genetics Service, Princess Anne Hospital, Coxford Road, Southampton, SO16 5YA, UK; katherine.lachlan{at}suht.swest.nhs.uk
  • Received 27 February 2007
  • Accepted 3 May 2007
  • Revised 30 April 2007
  • Published Online First 25 May 2007

Abstract

Background: The most commonly reported phenotypes described in patients with PTEN mutations are Bannayan–Riley–Ruvalcaba syndrome (BRRS), with childhood onset, macrocephaly, lipomas and developmental delay, and Cowden Syndrome (CS), an adult-onset condition recognised by mucocutaneous signs, with a risk of cancers, in particular those of the thyroid and breast. It has been suggested that BRRS and CS are the same condition, but the literature continues to separate them and seek a genotype–phenotype correlation.

Objective: To study the clinical features of patients with known PTEN mutations and observe any genotype–phenotype correlation.

Methods: In total, 42 people (25 probands and 17 non-probands) from 26 families of all ages with PTEN mutations were recruited through the UK clinical genetics services. A full clinical history and examination were undertaken.

Results: We were unable to demonstrate a genotype–phenotype correlation. Furthermore, our findings in a 31-year-old woman with CS and an exon 1 deletion refutes previous reports that whole exon deletions are only found in patients with a BRRS phenotype.

Conclusion: Careful phenotyping gives further support for the suggestion that BRRS and CS are actually one condition, presenting variably at different ages, as in other tumour-suppressor disorders such as neurofibromatosis type 1. This has important counselling implications, such as advice about cancer surveillance, for children diagnosed with BRRS.

Footnotes

  • Published Online First 25 May 2007

  • Competing interests: None declared.

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.